Vesper Healthcare Acquisition Corp. announced the pricing of its $400 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “VSPRU” tomorrow, Wednesday, September 30.
This new company aims to combine with a pharmaceutical or healthcare target that has a leading position in its respective therapeutic sector. It is led by President, CEO and Chairman Brenton L. Saunders and CFO and Director Nominee Dr. Manisha Narasimhan.
Total SPAC deal count for 2020 year-to-date is now 113 with $43.1 billion in gross proceeds raised. This offering is expected to close on Friday, October 2.
Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC are acting as joint book-running managers for the offering. Ellenoff Grossman & Schole LLP is serving as Issuer’s Counsel with Ropes & Gray LLP serving as Underwriter’s Counsel. Marcum LLP, serves as auditor. Continental Stock Transfer & Trust Company LLC is acting as trustee.